US Patent 6958335 Treatment of gastrointestinal stromal tumors
Patent 6958335 was granted and assigned to Novartis on October, 2005 by the United States Patent and Trademark Office.
Name
# Contributions
Last Contribution
Find more entities like US Patent 6958335 Treatment of gastrointestinal stromal tumors
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
